VeriMom¿Es p-cresyl isovalerate seguro durante el embarazo?
No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
Related ingredients
Frequently asked questions
- ¿Es p-cresyl isovalerate seguro durante el embarazo?
- No EU Annex II/III listing or harmonised CLP reproductive classification found; no SCCS or CIR safety opinion specifically for p‑cresyl isovalerate. JECFA evaluated p‑cresyl isovalerate (p‑tolyl isovalerate) as a flavouring and concluded 'no safety concern at current levels of intake' (2000). ECHA substance record shows REACH registration but no harmonised reproductive hazard classification; supplier SDSs report acute oral hazard statements (H302) but not H360/H361. Given the absence of reproductive or developmental toxicity evidence, hazard (h) and mechanism (m) are scored 0; dermal absorption from a small lipophilic ester used as a fragrance is likely low but measurable, so exposure (e) = 1. Sources: ECHA substance record, JECFA, PubChem/supplier pages, EWG listing.
- ¿Es p-cresyl isovalerate seguro durante la lactancia?
- Same evidence base as pregnancy: no harmonised CMR classification or reproductive/developmental studies for this specific compound. Dermal exposure from cosmetic use is expected to be low but measurable (fragrance ester), so exposure = 1. No data showing secretion in milk or specific lactation effects.
- ¿Es p-cresyl isovalerate seguro para la piel del bebé?
- No infant‑specific toxicity or developmental studies found. Following instructions to increase exposure for infants when adult absorption is measurable, exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and immature barrier function. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- ¿Cómo puntúa VeriMom a p-cresyl isovalerate?
- VeriMom puntúa p-cresyl isovalerate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a p-cresyl isovalerate en el embarazo?
- Consulta nuestra lista de alternativas seguras a p-cresyl isovalerate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.